News

Bharat Biotech acquires Chiron Behring Vaccines

Hyderabad-based vaccine major, Bharat Biotech will acquire 100% equity stake in Chiron Behring Vaccines in an all cash transaction, subject to a number of closing conditions which Bharat Biotech and GSK intend to complete in the coming weeks.

Feb 19, 2019

By : Team ABLE

Singapore’s Temasek backs eye specialty major Dr Agarwal’s Healthcare with INR 2.7 billion investment

The funds will be deployed for significant expansion of the chain within India, through strategic partnerships, acquisitions and new hospitals

Feb 15, 2019

By : Team ABLE

DBT calls for Research Associateship Applications for pursuing research in Biotechnology and Life Sciences

The Associateship is tenable in Premier Research Institutions/Universities including non-profit R&D Institutions within India. The Associateships are awarded under a program sponsored by the Department of Biotechnology

Feb 15, 2019

By : Team ABLE

Bio-Rad releases first FDA-cleared Digital PCR system and test for monitoring Chronic Myeloid Leukemia treatment response

The QXDxAutoDGddPCR System and QXDx BCR-ABL %IS Kit represent the first-ever digital PCR solution that can monitor and directly quantitate the molecular response of patients with chronic myeloid leukemia

Feb 15, 2019

By : Team ABLE

Pharmicell signs MoU with India’s ILBS to jointly develop stem cell therapy

Under the agreement, the two will jointly conduct clinical studies to develop a stem cell therapy to treat liver disease.

Feb 15, 2019

By : Team ABLE